1998
DOI: 10.1016/s0957-4166(98)00421-2
|View full text |Cite
|
Sign up to set email alerts
|

The synthesis of S-(+)-2,2-dimethylcyclopropane carboxylic acid: a precursor for cilastatin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
15
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(15 citation statements)
references
References 14 publications
0
15
0
Order By: Relevance
“…Thus, the strain might be used as an S -1 producer [30]. Presently, S -1 is mainly chemically prepared via asymmetric synthesis or resolution of racemic substrates such as (R, S -1) or (R, S -2) [1,25,27,28]. However, these methods suffered from certain flaws such as complex reactions, expensive chiral catalysts, harsh reaction conditions, low recovery and high cost.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the strain might be used as an S -1 producer [30]. Presently, S -1 is mainly chemically prepared via asymmetric synthesis or resolution of racemic substrates such as (R, S -1) or (R, S -2) [1,25,27,28]. However, these methods suffered from certain flaws such as complex reactions, expensive chiral catalysts, harsh reaction conditions, low recovery and high cost.…”
Section: Introductionmentioning
confidence: 99%
“…The (S)-(þ)-2,2-dimethylcyclopropane carboxylic acid (þ)-138, a key building block for the synthesis of cilastatin (137), was prepared from 2-methylpropene and chiral iron carbene complex via asymmetric cyclopropanation reaction and exhaustive ozonolysis with up to 92% ee (Wang et al 1998) (Scheme 10.34). (139) is an unnatural antibiotic that possesses an excellent antibacterial profile as well as enhanced chemical and metabolic stability.…”
Section: Asymmetric Cyclopropanation Reactionmentioning
confidence: 99%
“…S-(+)-DMcPA can be prepared either by a chemical processes of asymmetric catalysis or by racemate resolution. however, drawbacks such as the need for expensive chiral ligands, difficult reaction conditions and a number of complicated steps have been reported for the chemical processes (19). in the quest for a mild and cost-effective process for the chiral resolution of racemic DMcPA, alternative biocatalytic processes have recently been developed.…”
Section: Introductionmentioning
confidence: 99%